Pasithea Therapeutics
Price & Volume
Stats
See moreOpen | $0.70 |
Previous Close | $0.73 |
Day Range | $0.70-$0.70 |
52W Range | $0.65-$6.14 |
Market Cap | $5.4M |
Shares Short | 100,220 |
Financials
See moreRevenue (12 Mos) | $486,559 |
Revenue Growth (YoY) | 1,498.1% |
Gross Profit (12 Mos) | -$2,213 |
Diluted EPS | -$7.13 |
News
See moreYahoo Finance • 9 days ago
Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
Yahoo Finance • 17 days ago
Pasithea Therapeutics Announces Enrollment of Cohort 2 following Positive Safety Review Committee (SRC) Recommendation for its Ongoing Phase 1/1b Clinical Trial of PAS-004 in Adult NF1 Patients
Yahoo Finance • 27 days ago
Pasithea Therapeutics Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
Yahoo Finance • 28 days ago
Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
About
CEO | Dr. Tiago Reis Marques M.D., Ph.D. |
Address | 1111 Lincoln Road, Miami Beach, FL, United States, 33139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 4 |
